Skip to content

Educational reference only. Not medical advice, diagnosis, or treatment, and not dosing, injection, or purchasing guidance.Medical disclaimer

Retatrutide

The sentences below are limited to one FDA page opened for this draft.

  • FDA says retatrutide cannot be used in compounding under federal law, is not a component of an FDA-approved drug, and has not been found safe and effective for any condition.
  • FDA says it has warned telehealth companies marketing unapproved retatrutide, distributors selling it to compounders, and outsourcing facilities repackaging it.
  • FDA also names retatrutide among unapproved drugs sold with false research-use or not-for-human-consumption labels, including products sold for human use with dosing instructions.

This page does not describe receptor pharmacology or trial results. Those were not copied from a paper or label.

This page does not give doses, titration schedules, injection or implantation technique, preparation steps, or places to purchase a product.

Page record

  • Type: Compound
  • Domain: peptides
  • Evidence: Not rated
  • Status: reviewed
  • Last reviewed: 2026-11-20

Sources

Referenced by

A link from another wiki page is not evidence. Facts should point at the sources above.